VF
CASI

Virtu Financial’s CASI Pharmaceuticals CASI Stock Holding History

Virtu Financial’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11,278
Closed -$91K – 1619
2022
Q1 		$91K Buy
11,278
+3,197
+40% +$25.1K 0.01% 995
2021
Q4 		$65K Buy
8,081
+5,025
+164% +$50K 0.01% 1264
2021
Q3 		$36K Buy
+3,056
New +$41.3K ﹤0.01% 1315
2021
Q2 		– Sell
-6,611
Closed -$159K – 1550
2021
Q1 		$159K Buy
6,611
+5,366
+431% +$151K 0.01% 1169
2020
Q4 		$37K Sell
1,245
-2,605
-68% -$56.6K ﹤0.01% 1278
2020
Q3 		$59K Buy
+3,850
New +$72.5K 0.01% 801
2018
Q1 		– Sell
-1,212
Closed -$39K – 2001
2017
Q4 		$39K Sell
1,212
-2,867
-70% -$77.9K ﹤0.01% 2117
2017
Q3 		$72K Buy
+4,079
New +$47.6K ﹤0.01% 2155

Other funds holding CASI

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return
WSC
Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
B
Bailard Foster City, California $4.91B AUM 31.75% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Virtu Financial's CASI Position: Q2 2022 in Review

Virtu Financial sold out of CASI Pharmaceuticals (CASI) in Q2 2022, closing a stake of 11,278 shares — an estimated $91K sold.

Virtu Financial first reported a position in CASI in Q3 2017 and held it in 8 quarters. The position peaked at $159K in Q1 2021. 24 funds tracked by Wall St. Rank hold CASI as of Q2 2022.

  • Virtu Financial reported no remaining CASI Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Virtu Financial sold 11,278 CASI Pharmaceuticals shares in Q2 2022, an estimated $91K.
  • Virtu Financial first reported a position in CASI Pharmaceuticals in Q3 2017 and held it in 8 quarters.
  • Virtu Financial's CASI Pharmaceuticals position peaked at $159K in Q1 2021.
  • 24 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q2 2022.

Based on Virtu Financial's 13F filing for Q2 2022, filed 9 Aug 2022.